Authors' reply to: Letter from Arguedas et al
- PMID: 31783979
- DOI: 10.1016/j.vaccine.2019.09.110
Authors' reply to: Letter from Arguedas et al
Comment on
-
Direct effectiveness of pneumococcal polysaccharide vaccine against invasive pneumococcal disease and non-bacteremic pneumococcal pneumonia in elderly population in the era of pneumococcal conjugate vaccine: A case-control study.Vaccine. 2019 May 9;37(21):2797-2804. doi: 10.1016/j.vaccine.2019.04.017. Epub 2019 Apr 17. Vaccine. 2019. PMID: 31005428
-
Letter to the editor.Vaccine. 2019 Dec 10;37(52):7530-7531. doi: 10.1016/j.vaccine.2019.09.107. Vaccine. 2019. PMID: 31783978 No abstract available.
Similar articles
-
Letter to the editor.Vaccine. 2019 Dec 10;37(52):7530-7531. doi: 10.1016/j.vaccine.2019.09.107. Vaccine. 2019. PMID: 31783978 No abstract available.
-
Pneumococcal conjugate vaccines in different settings - Authors' reply.Lancet Infect Dis. 2019 Dec;19(12):1284. doi: 10.1016/S1473-3099(19)30630-9. Lancet Infect Dis. 2019. PMID: 31782391 No abstract available.
-
Clarifications about pneumococcal vaccines.Am J Health Syst Pharm. 2010 Feb 1;67(3):183; author reply 184. doi: 10.2146/ajhp090577. Am J Health Syst Pharm. 2010. PMID: 20101057 No abstract available.
-
Use of pneumococcal polysaccharide vaccines: no simple answers.J Infect. 2003 Feb;46(2):78-86. doi: 10.1053/jinf.2002.1113. J Infect. 2003. PMID: 12634068 Review.
-
Pneumococcal vaccines: present and future.Pediatr Ann. 2002 Apr;31(4):261-8. doi: 10.3928/0090-4481-20020401-10. Pediatr Ann. 2002. PMID: 11966249 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical